XXXX disease screening in adults: American College Of Preventive Medicine position statement on preventive practice.

@entity1 @entity3657 @entity301 @entity543 @entity1028 @entity65
CONTEXT: @entity65 , including @entity301 ( @entity301 ), @entity543 ( @entity543 ), @entity3657 ( @entity3657 ), and @entity1028 ( @entity1028 ), affect millions of U.S. adults and are leading causes of morbidity and mortality. There is some uncertainty regarding the utility of certain screening tests for prevention of @entity65 and mortality. EVIDENCE ACQUISITION: Current guidelines and studies pertaining to @entity301 , @entity543 , @entity3657 , and @entity1028 screening in the adult population were reviewed. EVIDENCE SYNTHESIS: @entity301 risk can be estimated by the Framingham Risk Score (FRS), which is valuable in identifying high-risk asymptomatic adults who may benefit from preventive treatments. There is moderate certainty that the benefits of screening do not outweigh the harms for individuals with asymptomatic @entity543 . The potential harms associated with routine @entity3657 screening in asymptomatic adults are also likely to exceed benefits. Ultrasonography is a safe, noninvasive, and reliable screening test used to identify AAAs for treatment in @entity1 aged >65 years who have ever smoked. CONCLUSIONS: American College of Preventive Medicine (ACPM) recommends @entity301 risk assessment using the FRS to guide risk-based therapy. ACPM does not recommend routine screening of the general adult population using electrocardiogram, exercise-stress testing, computed tomography scanning, ankle-brachial index, carotid intima medial thickness, or emerging risk factors, including high-sensitivity C-reactive protein (hs-CRP). ACPM does not recommend routine screening of the general adult population for @entity543 or @entity3657 . ACPM recommends one-time @entity1028 screening in @entity1 aged 65-75 years who have ever smoked. Routine @entity1028 screening in @entity1 is not recommended.
